UPDATE: JPMorgan Downgrades Atara Biotherapeutics (ATRA) to Neutral
Tweet Send to a Friend
(Updated - July 13, 2022 6:17 AM EDT)
JPMorgan analyst Anupam Rama downgraded Atara Biotherapeutics (NASDAQ: ATRA) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama downgraded Atara Biotherapeutics (NASDAQ: ATRA) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
